-
1
-
-
79952232216
-
Global cancer statistics
-
Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
-
2
-
-
63249118690
-
Screening and prostate-cancer mortality in a randomized European study
-
Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, et al. (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360: 1320-1328.
-
(2009)
N Engl J Med
, vol.360
, pp. 1320-1328
-
-
Schroder, F.H.1
Hugosson, J.2
Roobol, M.J.3
Tammela, T.L.4
Ciatto, S.5
-
3
-
-
84856200634
-
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up
-
Andriole GL, Crawford ED, Grubb RL, (2012) Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 104: 125-132.
-
(2012)
J Natl Cancer Inst
, vol.104
, pp. 125-132
-
-
Andriole, G.L.1
Crawford, E.D.2
Grubb, R.L.3
-
4
-
-
0037304517
-
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
-
Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, et al. (2003) Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169: 517-523.
-
(2003)
J Urol
, vol.169
, pp. 517-523
-
-
Han, M.1
Partin, A.W.2
Zahurak, M.3
Piantadosi, S.4
Epstein, J.I.5
-
5
-
-
84873270023
-
Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience
-
Busch J, Stephan C, Herold A, Erber B, Kempkensteffen C, et al. (2012) Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience. BJU Int 110: E985-990.
-
(2012)
BJU Int
, vol.110
-
-
Busch, J.1
Stephan, C.2
Herold, A.3
Erber, B.4
Kempkensteffen, C.5
-
6
-
-
41149131215
-
A nomogram predicting long-term biochemical recurrence after radical prostatectomy
-
Suardi N, Porter CR, Reuther AM, Walz J, Kodama K, et al. (2008) A nomogram predicting long-term biochemical recurrence after radical prostatectomy. Cancer 112: 1254-1263.
-
(2008)
Cancer
, vol.112
, pp. 1254-1263
-
-
Suardi, N.1
Porter, C.R.2
Reuther, A.M.3
Walz, J.4
Kodama, K.5
-
7
-
-
0037319283
-
Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen
-
Freedland SJ, Sutter ME, Dorey F, Aronson WJ, (2003) Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. Urology 61: 365-369.
-
(2003)
Urology
, vol.61
, pp. 365-369
-
-
Freedland, S.J.1
Sutter, M.E.2
Dorey, F.3
Aronson, W.J.4
-
8
-
-
22844434877
-
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
-
Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, et al. (2005) Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294: 433-439.
-
(2005)
JAMA
, vol.294
, pp. 433-439
-
-
Freedland, S.J.1
Humphreys, E.B.2
Mangold, L.A.3
Eisenberger, M.4
Dorey, F.J.5
-
9
-
-
0033526309
-
Natural history of progression after PSA elevation following radical prostatectomy
-
Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, et al. (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281: 1591-1597.
-
(1999)
JAMA
, vol.281
, pp. 1591-1597
-
-
Pound, C.R.1
Partin, A.W.2
Eisenberger, M.A.3
Chan, D.W.4
Pearson, J.D.5
-
10
-
-
33646945083
-
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
-
Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, et al. (2006) Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 98: 715-717.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 715-717
-
-
Stephenson, A.J.1
Scardino, P.T.2
Eastham, J.A.3
Bianco Jr., F.J.4
Dotan, Z.A.5
-
11
-
-
34047099256
-
Role of nomograms for prostate cancer in 2007
-
Chun FK, Karakiewicz PI, Huland H, Graefen M, (2007) Role of nomograms for prostate cancer in 2007. World J Urol 25: 131-142.
-
(2007)
World J Urol
, vol.25
, pp. 131-142
-
-
Chun, F.K.1
Karakiewicz, P.I.2
Huland, H.3
Graefen, M.4
-
13
-
-
84867394102
-
Association of GSTM1 null allele with prostate cancer risk: evidence from 36 case-control studies
-
Wei B, Xu Z, Zhou Y, Ruan J, Cheng H, et al. (2012) Association of GSTM1 null allele with prostate cancer risk: evidence from 36 case-control studies. PLoS One 7: e46982.
-
(2012)
PLoS One
, vol.7
-
-
Wei, B.1
Xu, Z.2
Zhou, Y.3
Ruan, J.4
Cheng, H.5
-
14
-
-
66549083321
-
Established prostate cancer susceptibility variants are not associated with disease outcome
-
Wiklund FE, Adami HO, Zheng SL, Stattin P, Isaacs WB, et al. (2009) Established prostate cancer susceptibility variants are not associated with disease outcome. Cancer Epidemiol Biomarkers Prev 18: 1659-1662.
-
(2009)
Cancer Epidemiol Biomarkers Prev
, vol.18
, pp. 1659-1662
-
-
Wiklund, F.E.1
Adami, H.O.2
Zheng, S.L.3
Stattin, P.4
Isaacs, W.B.5
-
15
-
-
84886091040
-
Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy
-
Cotignola J, Leonardi DB, Shahabi A, Acuna AD, Stern MC, et al. (2012) Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy. Prostate Cancer Prostatic Dis.
-
(2012)
Prostate Cancer Prostatic Dis
-
-
Cotignola, J.1
Leonardi, D.B.2
Shahabi, A.3
Acuna, A.D.4
Stern, M.C.5
-
16
-
-
71349088365
-
Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity
-
Nock NL, Bock C, Neslund-Dudas C, Beebe-Dimmer J, Rundle A, et al. (2009) Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity. Cancer Causes Control 20: 1915-1926.
-
(2009)
Cancer Causes Control
, vol.20
, pp. 1915-1926
-
-
Nock, N.L.1
Bock, C.2
Neslund-Dudas, C.3
Beebe-Dimmer, J.4
Rundle, A.5
-
17
-
-
33749055943
-
Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis
-
Agalliu I, Lin DW, Salinas CA, Feng Z, Stanford JL, (2006) Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. Prostate 66: 1535-1541.
-
(2006)
Prostate
, vol.66
, pp. 1535-1541
-
-
Agalliu, I.1
Lin, D.W.2
Salinas, C.A.3
Feng, Z.4
Stanford, J.L.5
-
18
-
-
84867303446
-
Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence
-
Dluzniewski PJ, Wang MH, Zheng SL, De Marzo AM, Drake CG, et al. (2012) Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence. Cancer Epidemiol Biomarkers Prev 21: 1774-1782.
-
(2012)
Cancer Epidemiol Biomarkers Prev
, vol.21
, pp. 1774-1782
-
-
Dluzniewski, P.J.1
Wang, M.H.2
Zheng, S.L.3
De Marzo, A.M.4
Drake, C.G.5
-
19
-
-
77951748989
-
Methylated genes as potential biomarkers in prostate cancer
-
Phe V, Cussenot O, Roupret M, (2010) Methylated genes as potential biomarkers in prostate cancer. BJU Int 105: 1364-1370.
-
(2010)
BJU Int
, vol.105
, pp. 1364-1370
-
-
Phe, V.1
Cussenot, O.2
Roupret, M.3
-
21
-
-
84861153520
-
Global methylation profiling for risk prediction of prostate cancer
-
Mahapatra S, Klee EW, Young CY, Sun Z, Jimenez RE, et al. (2012) Global methylation profiling for risk prediction of prostate cancer. Clin Cancer Res 18: 2882-2895.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 2882-2895
-
-
Mahapatra, S.1
Klee, E.W.2
Young, C.Y.3
Sun, Z.4
Jimenez, R.E.5
-
22
-
-
79959885041
-
Association of tissue promoter methylation levels of APC, TGFbeta2, HOXD3 and RASSF1A with prostate cancer progression
-
Liu L, Kron KJ, Pethe VV, Demetrashvili N, Nesbitt ME, et al. (2011) Association of tissue promoter methylation levels of APC, TGFbeta2, HOXD3 and RASSF1A with prostate cancer progression. Int J Cancer 129: 2454-2462.
-
(2011)
Int J Cancer
, vol.129
, pp. 2454-2462
-
-
Liu, L.1
Kron, K.J.2
Pethe, V.V.3
Demetrashvili, N.4
Nesbitt, M.E.5
-
23
-
-
37449024720
-
CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer
-
Ellinger J, Haan K, Heukamp LC, Kahl P, Buttner R, et al. (2008) CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer. Prostate 68: 42-49.
-
(2008)
Prostate
, vol.68
, pp. 42-49
-
-
Ellinger, J.1
Haan, K.2
Heukamp, L.C.3
Kahl, P.4
Buttner, R.5
-
24
-
-
38649101553
-
CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer
-
Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, et al. (2008) CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Urology 71: 161-167.
-
(2008)
Urology
, vol.71
, pp. 161-167
-
-
Ellinger, J.1
Bastian, P.J.2
Jurgan, T.3
Biermann, K.4
Kahl, P.5
-
25
-
-
20344366824
-
Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy
-
Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, et al. (2005) Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Clin Cancer Res 11: 4037-4043.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 4037-4043
-
-
Bastian, P.J.1
Palapattu, G.S.2
Lin, X.3
Yegnasubramanian, S.4
Mangold, L.A.5
-
26
-
-
38449120703
-
CD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized disease
-
Woodson K, O'Reilly KJ, Ward DE, Walter J, Hanson J, et al. (2006) CD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized disease. Epigenetics 1: 183-186.
-
(2006)
Epigenetics
, vol.1
, pp. 183-186
-
-
Woodson, K.1
O'Reilly, K.J.2
Ward, D.E.3
Walter, J.4
Hanson, J.5
-
27
-
-
28544442448
-
Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy
-
Rosenbaum E, Hoque MO, Cohen Y, Zahurak M, Eisenberger MA, et al. (2005) Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy. Clinical Cancer Research 11: 8321-8325.
-
(2005)
Clinical Cancer Research
, vol.11
, pp. 8321-8325
-
-
Rosenbaum, E.1
Hoque, M.O.2
Cohen, Y.3
Zahurak, M.4
Eisenberger, M.A.5
-
28
-
-
77951748989
-
Methylated genes as potential biomarkers in prostate cancer
-
Phe V, Cussenot O, Roupret M, (2010) Methylated genes as potential biomarkers in prostate cancer. BJU International 105: 1364-1370.
-
(2010)
BJU International
, vol.105
, pp. 1364-1370
-
-
Phe, V.1
Cussenot, O.2
Roupret, M.3
-
29
-
-
33846221516
-
Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy
-
Discussion 674
-
Bastian PJ, Ellinger J, Heukamp LC, Kahl P, Muller SC, et al. (2007) Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy. Eur Urol 51: 665-674; discussion 674.
-
(2007)
Eur Urol
, vol.51
, pp. 665-674
-
-
Bastian, P.J.1
Ellinger, J.2
Heukamp, L.C.3
Kahl, P.4
Muller, S.C.5
-
30
-
-
0035870248
-
A gene hypermethylation profile of human cancer
-
Esteller M, Corn PG, Baylin SB, Herman JG, (2001) A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229.
-
(2001)
Cancer Res
, vol.61
, pp. 3225-3229
-
-
Esteller, M.1
Corn, P.G.2
Baylin, S.B.3
Herman, J.G.4
-
31
-
-
12144289173
-
Hypermethylation of CpG islands in primary and metastatic human prostate cancer
-
Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, et al. (2004) Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 64: 1975-1986.
-
(2004)
Cancer Res
, vol.64
, pp. 1975-1986
-
-
Yegnasubramanian, S.1
Kowalski, J.2
Gonzalgo, M.L.3
Zahurak, M.4
Piantadosi, S.5
-
33
-
-
84959801619
-
Statistical aspects of the analysis of data from retrospective studies of disease
-
Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
-
(1959)
J Natl Cancer Inst
, vol.22
, pp. 719-748
-
-
Mantel, N.1
Haenszel, W.2
-
34
-
-
0030922816
-
Bias in meta-analysis detected by a simple, graphical test
-
Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
-
(1997)
BMJ
, vol.315
, pp. 629-634
-
-
Egger, M.1
Davey Smith, G.2
Schneider, M.3
Minder, C.4
-
35
-
-
0035918543
-
Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk
-
Gsur A, Haidinger G, Hinteregger S, Bernhofer G, Schatzl G, et al. (2001) Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer 95: 152-155.
-
(2001)
Int J Cancer
, vol.95
, pp. 152-155
-
-
Gsur, A.1
Haidinger, G.2
Hinteregger, S.3
Bernhofer, G.4
Schatzl, G.5
-
36
-
-
84859297213
-
Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies
-
Trock BJ, Brotzman MJ, Mangold LA, Bigley JW, Epstein JI, et al. (2012) Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies. BJU Int 110: 56-62.
-
(2012)
BJU Int
, vol.110
, pp. 56-62
-
-
Trock, B.J.1
Brotzman, M.J.2
Mangold, L.A.3
Bigley, J.W.4
Epstein, J.I.5
-
37
-
-
19944429845
-
A quantitative promoter methylation profile of prostate cancer
-
Jeronimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, et al. (2004) A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 10: 8472-8478.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 8472-8478
-
-
Jeronimo, C.1
Henrique, R.2
Hoque, M.O.3
Mambo, E.4
Ribeiro, F.R.5
|